IO BIOTECH INC
(NASDAQ: IOBT)
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.
1.470
-
(-%)
Range
- - -
(-%)
Open
-
Previous Close
1.470
Bid Price
2.070
Bid Volume
22
Ask Price
2.290
Ask Volume
8
Volume
91,545
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis